WO2002024927A3 - Regulation de la proteine humaine de type precurseur de adam-ts1 - Google Patents

Regulation de la proteine humaine de type precurseur de adam-ts1 Download PDF

Info

Publication number
WO2002024927A3
WO2002024927A3 PCT/EP2001/010700 EP0110700W WO0224927A3 WO 2002024927 A3 WO2002024927 A3 WO 2002024927A3 EP 0110700 W EP0110700 W EP 0110700W WO 0224927 A3 WO0224927 A3 WO 0224927A3
Authority
WO
WIPO (PCT)
Prior art keywords
precursor
protein
human adam
regulation
reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/010700
Other languages
English (en)
Other versions
WO2002024927A2 (fr
Inventor
Jiing-Ren Liou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to AU2001289886A priority Critical patent/AU2001289886A1/en
Publication of WO2002024927A2 publication Critical patent/WO2002024927A2/fr
Publication of WO2002024927A3 publication Critical patent/WO2002024927A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention se rapporte à des réactifs qui régulent la protéine humaine de type précurseur de ADAM-TS1 et à des réactifs qui se lient au produit génique de la protéine humaine de type précurseur de ADAM-TS1. Ces réactifs peuvent jouer un rôle pour la prévention, l'amélioration ou la correction des dysfonctionnements ou des maladies incluant, entre autres, les troubles cardio-vasculaires et hépatiques et les broncho-pneumopathies chroniques obstructives.
PCT/EP2001/010700 2000-09-20 2001-09-17 Regulation de la proteine humaine de type precurseur de adam-ts1 Ceased WO2002024927A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001289886A AU2001289886A1 (en) 2000-09-20 2001-09-17 Regulation of human adam-ts 1 precursor-like protein

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23420100P 2000-09-20 2000-09-20
US60/234,201 2000-09-20
US30715801P 2001-07-24 2001-07-24
US60/307,158 2001-07-24

Publications (2)

Publication Number Publication Date
WO2002024927A2 WO2002024927A2 (fr) 2002-03-28
WO2002024927A3 true WO2002024927A3 (fr) 2002-11-07

Family

ID=26927667

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/010700 Ceased WO2002024927A2 (fr) 2000-09-20 2001-09-17 Regulation de la proteine humaine de type precurseur de adam-ts1

Country Status (2)

Country Link
AU (1) AU2001289886A1 (fr)
WO (1) WO2002024927A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6683165B1 (en) 1999-04-13 2004-01-27 Genome Therapeutics Corporation Human gene relating to respiratory diseases and obesity
AU2002319703A1 (en) 2001-07-27 2003-02-17 Wyeth Aggrecanase molecules
AU2002351945A1 (en) * 2001-11-13 2003-05-26 Universite De Liege A new disintegrin and metalloproteinase with thrombospondin type i repeats polynucleotide and its encoded polypeptide
CN111272746A (zh) * 2020-03-09 2020-06-12 中国水产科学研究院东海水产研究所 一种比色法测定水产品中游离氨基酸总量的方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998000555A1 (fr) * 1996-07-03 1998-01-08 Prockop Darwin J N-proteinase de recombinaison, et production, procedes et utilisations de cette derniere
WO1999061656A2 (fr) * 1998-05-29 1999-12-02 Wisconsin Alumni Research Foundation Agent et methode pour moduler la migration cellulaire
WO2001059133A1 (fr) * 2000-02-14 2001-08-16 Merck Patent Gmbh Proteine larcap-1 associee au carcinome du larynx
WO2001083782A2 (fr) * 2000-05-04 2001-11-08 Sugen, Inc. Nouvelles proteases
WO2002016564A2 (fr) * 2000-08-22 2002-02-28 Lexicon Genetics Incorporated Nouvelles proteases humaines et polynucleotides codant lesdites proteases

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998000555A1 (fr) * 1996-07-03 1998-01-08 Prockop Darwin J N-proteinase de recombinaison, et production, procedes et utilisations de cette derniere
WO1999061656A2 (fr) * 1998-05-29 1999-12-02 Wisconsin Alumni Research Foundation Agent et methode pour moduler la migration cellulaire
WO2001059133A1 (fr) * 2000-02-14 2001-08-16 Merck Patent Gmbh Proteine larcap-1 associee au carcinome du larynx
WO2001083782A2 (fr) * 2000-05-04 2001-11-08 Sugen, Inc. Nouvelles proteases
WO2002016564A2 (fr) * 2000-08-22 2002-02-28 Lexicon Genetics Incorporated Nouvelles proteases humaines et polynucleotides codant lesdites proteases

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
BOLZ^A^1 H ET AL: "Characterization of ADAMTS14, a novel member of the ADAMTS metalloproteinase family", BIOCHIMICA ET BIOPHYSICA ACTA. GENE STRUCTURE AND EXPRESSION, ELSEVIER, AMSTERDAM, NL, vol. 1522, no. 3, 30 December 2001 (2001-12-30), pages 221 - 225, XP004331262, ISSN: 0167-4781 *
DATABASE EMBL [online] 14 December 2001 (2001-12-14), PLOWMAN G. ET AL., Database accession no. AX319856 *
DATABASE EMBL [online] 16 January 2001 (2001-01-16), DIAS NETO E. ET AL, Database accession no. BF823025 *
DATABASE EMBL [online] 2 December 1999 (1999-12-02), KIMBLE J.E. ET AL.: "WO9961656", Database accession no. AAY53900 *
DATABASE EMBL [online] 22 August 2000 (2000-08-22), FROHME M.: "Homo sapiens EST, clone 3.3-n2", XP002201628, Database accession no. AJ403134 *
DATABASE EMBL [online] 23 March 2002 (2002-03-23), WALKE W.D. ET AL., Database accession no. AX392451 *
DATABASE EMBL [online] 24 November 1998 (1998-11-24), COLIGE A.C.: "Homo sapiens mRNA for procollagen I-N proteinase", XP002201629, Database accession no. AJ003125 *
DATABASE EMBL [online] 6 May 1999 (1999-05-06), BIRREN B. ET AL.: "Homo sapiens, clone RP11-91A1", XP002201630, Database accession no. AC007484 *
DATABASE EMBL [online] 6 September 2001 (2001-09-06), DUECKER K. ET AL., Database accession no. AX211285 *
DATABASE EMBL [online] 8 January 1998 (1998-01-08), COLIGE A. ET AL.: "WO9800555", Database accession no. AAW47028 *
DIAS NETO EMMANUEL ET AL: "Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 97, no. 7, 28 March 2000 (2000-03-28), March 28, 2000, pages 3491 - 3496, XP002201627, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
AU2001289886A1 (en) 2002-04-02
WO2002024927A2 (fr) 2002-03-28

Similar Documents

Publication Publication Date Title
WO2002006453A3 (fr) Regulation de protease a serine humaine de type desc1
WO2002020731A3 (fr) Regulation de l'enzyme humaine du type proteine disulfide isomerase
WO2002061092A3 (fr) Regulation de la lysyl oxydase humaine
WO2002024927A3 (fr) Regulation de la proteine humaine de type precurseur de adam-ts1
WO2001077149A3 (fr) Regulation d'une proteine gpcr type cyslt2 humaine
WO2002026999A3 (fr) Regulation de la proteine humaine de type adam-ts
WO2002032938A3 (fr) Regulation de la proteine humaine de type pgc-1
WO2002057461A3 (fr) Regulation de la metalloprotease a zinc de type adam-ts humaine
WO2002062974A3 (fr) Regulation de la proteine humaine elongase hselo1
WO2003035862A3 (fr) Regulation d'une proteine contenant une signature d'arginase humaine
WO2002081705A3 (fr) Regulation de la proteine humaine de type acetyltransferase gnat
WO2002052016A3 (fr) Regulation d'enzyme de type proteine l-isoaspartate o-methyltransferase humaine
WO2002092798A3 (fr) Regulation d'une proteine humaine de type 2c de phosphatase acide phosphatidique
WO2002062975A3 (fr) Regulation de la proteine humaine du type elongase hselo1
WO2002053714A3 (fr) Regulation de la phosphatidylinositol-4-phosphate 5-kinase humaine
WO2002072825A3 (fr) Regulation de la proteine humaine de type mrp5
WO2002046403A3 (fr) Regulation de la proteine humaine du type 'patched'
WO2002053756A3 (fr) Regulation de glucosamine-6-phosphate desaminase humaine
WO2002055681A3 (fr) Regulation de la tau-tubuline kinase humaine
WO2002083887A3 (fr) Regulation de la proteine de type methionine aminopeptidase humaine
WO2002097074A3 (fr) Regulation de l'enzyme de type proteine phosphatase 2c humaine
WO2002022791A3 (fr) Regulation de la pyridoxine 5'-phosphate oxydase humaine
WO2002018566A3 (fr) Regulation d'enzyme de type l-asparaginase humaine
WO2003025174A3 (fr) Regulation de la proteine humaine de type mrp1
WO2002090543A3 (fr) Régulation de la protéine semblable à celle de type 2c de la phosphatase de l'acide phosphatidique humain

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP